Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine

Cancer Immunology, Immunotherapy

Volumn 60, Issue 5, 2011, Pages 629-638

  Vasievich, Elizabeth A ^a   Chen, Weihsu ^b   Huang, Leaf ^a  

^a University of North Carolina   (United States)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

Cationic lipid; Cervical cancer; Enantiomers; Therapeutic vaccine

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CD86 ANTIGEN; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN E7;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOSE RESPONSE; DRUG EFFICACY; ENANTIOMER; ENANTIOSELECTIVITY; ENCAPSULATION; FEMALE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION; UTERINE CERVIX CANCER; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD8; CANCER VACCINES; CYTOKINES; DENDRITIC CELLS; FATTY ACIDS, MONOUNSATURATED; FEMALE; INTERFERON-ALPHA; INTERFERON-GAMMA; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; PAPILLOMAVIRUS E7 PROTEINS; QUATERNARY AMMONIUM COMPOUNDS; T-LYMPHOCYTES, CYTOTOXIC; UTERINE CERVICAL NEOPLASMS;

EID: 79955542554     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-0970-1     Document Type: Article

References (18)

1. C Palena J Schlom 2010 Vaccines against human carcinomas: strategies to improve antitumor immune responses J Biomed Biotechnol 2010 380697 20300434 10.1155/2010/380697
2. FO Nestle S Alijagic M Gilliet, et al. 1998 Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med 4 328 332 9500607 10.1038/nm0398-328 1:CAS:528:DyaK1cXhs1Kisrc%3D (Pubitemid 28144092)
3. FJ Hsu C Benike F Fagnoni, et al. 1996 Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat Med 2 52 58 8564842 10.1038/nm0196-52 1:CAS:528:DyaK28XivVSnuw%3D%3D (Pubitemid 26028073)
4. AD Syrengelas TT Chen R Levy 1996 DNA immunization induces protective immunity against B-cell lymphoma Nat Med 2 1038 1041 8782465 10.1038/nm0996-1038 1:CAS:528:DyaK28XlsFemsrw%3D (Pubitemid 26306846)
5. E De Gregorio E Tritto R Rappuoli 2008 Alum adjuvanticity: unraveling a century old mystery Eur J Immunol 38 2068 2071 18651701 10.1002/eji.200838648
6. DM Harper EL Franco C Wheeler, et al. 2004 Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 1757 1765 15541448 10.1016/S0140-6736(04)17398-4 1:CAS:528:DC%2BD2cXpslGju78%3D (Pubitemid 39488060)
7. ER Francotte 2001 Enantioselective chromatography as a powerful alternative for the preparation of drug enantiomers J Chromatogr A 906 379 397 11215898 10.1016/S0021-9673(00)00951-1 1:CAS:528:DC%2BD3MXnvFek
8. FDA's policy statement for the development of new stereoisomeric drugs (1992) Chirality 4:338-340
9. M Simonyi 1984 On chiral drug action Med Res Rev 4 359 413 6087043 10.1002/med.2610040304 1:CAS:528:DyaL2cXkvVegtLs%3D (Pubitemid 14073189)
10. SF Schlossman J Herman A Yaron 1969 Antigen recognition: in vitro studies on the specificity of the cellular immune response J Exp Med 130 1031 1045 5347692 10.1084/jem.130.5.1031 1:CAS:528:DyaE3cXitVSktw%3D%3D
11. P Barbier C Benezra 1982 Stereospecificity of allergic contact dermatitis (ACD) induced by two natural enantiomers, (+)- and (-)-frullanolides, in guinea pigs Naturwissenschaften 69 296 297 7110364 10.1007/BF00396445 1:CAS:528:DyaL38XkslSltLg%3D (Pubitemid 12066649)
12. W Chen W Yan L Huang 2008 A simple but effective cancer vaccine consisting of an antigen and a cationic lipid Cancer Immunol Immunother 57 517 530 17724588 10.1007/s00262-007-0390-4 1:CAS:528:DC%2BD1cXhtV2isro%3D (Pubitemid 351170535)
13. W Yan W Chen L Huang 2007 Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines Mol Immunol 44 3672 3681 17521728 10.1016/j.molimm.2007.04.009 1:CAS:528: DC%2BD2sXmtVSks7Y%3D (Pubitemid 46817670)
14. KY Lin FG Guarnieri KF Staveley-O'Carroll, et al. 1996 Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Res 56 21 26 8548765 1:CAS:528:DyaK28Xit1CjtA%3D%3D (Pubitemid 26010379)
15. + T cells J Immunol 171 17 21 12816977 1:CAS:528:DC%2BD3sXks12jtrg%3D (Pubitemid 36745267)
16. W Chen L Huang 2008 Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine Mol Pharm 5 464 471 18266319 10.1021/mp700126c 1:CAS:528:DC%2BD1cXhsl2qurc%3D (Pubitemid 351929830)
17. Y Xu FC Szoka Jr 1996 Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection Biochemistry 35 5616 5623 8639519 10.1021/bi9602019 1:CAS:528:DyaK28XisV2jsbg%3D (Pubitemid 26143656)
18. W Yan W Chen L Huang 2008 Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine J Control Release 130 22 28 18554742 10.1016/j.jconrel.2008.05.005 1:CAS:528:DC%2BD1cXps1ahur4%3D